<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01327274</url>
  </required_header>
  <id_info>
    <org_study_id>FD003341-03-06</org_study_id>
    <secondary_id>FD-R-01FD-03341</secondary_id>
    <nct_id>NCT01327274</nct_id>
  </id_info>
  <brief_title>Multicenter Trial of Magnetic Mini-Mover for Pectus Excavatum</brief_title>
  <acronym>3MP</acronym>
  <official_title>Phase 3 Multicenter Study of Magnetic Mini-Mover for Pectus Excavatum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Michael Harrison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shriners Hospitals for Children</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Mercy Hospital Kansas City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a Phase 3, multicenter, non-randomized study to evaluate the safety and
      efficacy of the next-generation outpatient Magnetic Mini-Mover Procedure (3MP) in 15 patients
      aged 8-14 years for the correction of pectus excavatum ('sunken chest'). 3MP for pectus
      excavatum uses a magnetically coupled implant to pull the sternum forward and gradually
      remodel the deformed costal cartilage. The Funding Source for this trial is the FDA Office of
      Orphan Products Development (Grant #R01 FD003341).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pectus excavatum is the most common congenital chest wall abnormality in children. The
      investigators have developed a novel method of achieving gradual deformation/reformation of
      chest wall cartilage. A magnetic force field is used to apply controlled, sustained force to
      promote biologic reformation of structural cartilage. A magnet is implanted on the sternum
      and secured through a 2-inch subxiphoid incision as a one-hour outpatient procedure. The
      magnet (and sternum) is pulled outward by another magnet suspended in a novel, low-profile,
      lightweight device previously molded to the patient's anterior chest wall. The low-profile,
      non-obtrusive anterior chest wall prosthesis is held in place by the force field between the
      two magnets.

      In the single-center, FDA-funded trial (IDE G050196), the investigators tested proof of
      concept, safety and probable benefit of this procedure in 10. In this Phase III multicenter
      trial, the investigators will further test the safety and efficacy of the procedure in 15
      otherwise healthy patients with moderate-to-severe PE, ages 8 to 14. The investigators will
      be using the next generation Magnetic Mini-Mover Magnimplant device (IDE G090006), a design
      the investigators believe is much improved in terms of safety and ease of
      implantation/explantation. Implantation of the Magnimplant will be accomplished in an
      outpatient procedure. The investigators will document the rate of correction by comparing
      chest X-ray measurement of the Pectus Severity Index prior to implantation, to that measured
      after the magnet is removed. Treatment will last 18-24 months, depending on correction and
      when the patient has completed his or her pubertal growth spurt, as documented by hand x-ray.
      Explant of the device will be accomplished in an outpatient procedure. The investigators will
      document safety with an EKG prior to implantation, one month post-implantation, and finally
      after the magnet is removed. The investigators will document efficacy by comparing pre- and
      post-treatment PSI, as well as by evaluating patient satisfaction with a post-procedure
      Quality of Life-type survey. Long-term follow-up will occur at 6, 12, 18, and 24 months after
      explantation.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Adverse Reactions</measure>
    <time_frame>During treatment, 24 months</time_frame>
    <description>All adverse reactions were recorded and reported, including complications from implantation of the device, complications from application of the external device over time (e.g., changes in skin; infection; changes in cardiac electrical function).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comfort and Brace Wear During Treatment</measure>
    <time_frame>During treatment, 24 months</time_frame>
    <description>Comfort of the external brace directly affects compliance (i.e., bracewear) and compliance were be measured throughout treatment. In addition, the satisfaction of the patient and family will be measured using a standard Quality of Life (QOL) questionnaire administered 1 month after implanting the device and 1 month after removing the device.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chest Wall Correction, by Pectus Severity Index</measure>
    <time_frame>24 months</time_frame>
    <description>Though not powered to determine efficacy, preliminary efficacy data, as measured by pre and post treatment Pectus Severity Index (Haller Index), was also collected. Pre-treatment Haller Index was assessed based on computed tomography (CT) of the chest. One month after implant removal, patients underwent repeat chest CT to evaluate chest wall correction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction During the Treatment</measure>
    <time_frame>One month and one year after explant.</time_frame>
    <description>. Patients were asked to fill out questionnaire at 2 intervals: 1 month after explant and 1 year after explant</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Pectus Excavatum</condition>
  <arm_group>
    <arm_group_label>Treatment Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This is a non-randomized study in which otherwise healthy patients, ages 8-14, with severe pectus excavatum (PSI &gt; 3.5) will undergo the interventional treatment arm by having outpatient surgery and the Magnetic MIni-Mover Magnimplant procedure is performed during which the magnetic implant is surgically placed. After 2 years of treatment with the implanted magnet and brace treatment, the Magnetic Mini-Mover Magnimplant will be explanted. After surgery and recovery, all subjects will be fitted for an orthotic brace, which houses the external magnet and records brace-wear compliance. They will undergo 3MP treatment for 18-24 months, enough to attempt to improve their PSI (&lt; 3.25).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Magnetic Mini-Mover Procedure (Magnimplant)</intervention_name>
    <description>This is a non-randomized study in which otherwise healthy patients, ages 8-14, with severe pectus excavatum (PSI &gt; 3.5) will undergo the Magnetic Mini-Mover procedure outpatient surgery. The Magnimplant or Magnetic Mini-Mover device implant will surgically implanted on the sternum. Patients will be required to wear a custom-fitted orthotic brace, which houses the external magnet and records brace-wear compliance. They will undergo brace treatment for 18-24 months, enough to attempt to improve their PSI (&lt; 3.25). Patients will be seen in clinic at least monthly until treatment is complete and the magnimplant device will be explanted from their sternum.</description>
    <arm_group_label>Treatment Arm</arm_group_label>
    <other_name>IDE G090006</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Otherwise healthy male or female with pectus excavatum deformity

          -  Between 8 and 14 years of age (inclusive)

          -  Pectus Severity Index &gt; 3.5 (normal 2.56). NOTE: A pectus severity index of 3.5 or
             greater qualifies as a moderate-to-severe deformity, and justifies operative
             intervention

          -  Ability to read, speak and understand English

          -  Onset of rapid growth of puberty documented by hand/wrist x-ray in early to
             mid-puberty (defined as bone age in females of 7-13 years, and males of 9-14 years)

        Exclusion Criteria:

          -  Other congenital anomalies (including significant skeletal anomalies such as
             scoliosis, bony fusion involving the cervical vertebrae) not directly related to
             pectus excavatum

          -  Bleeding disorders

          -  Heart disease (including arrhythmia)

          -  Persons with active implantable medical devices (AIMD) such as pacemakers

          -  Persons with a relative(s) or close family friend(s) living within their households
             and having a pacemaker

          -  Persons with arteriovenous malformations

          -  Chest deformity more complicated than pectus excavatum (e.g., Poland syndrome)

          -  Persons for whom a foreign body implant would pose a risk (e.g., immunodeficiency)

          -  Persons at increased risk for general anesthesia (e.g., history of malignant
             hyperthermia)

          -  Respiratory conditions that have required steroid treatment (e.g., prednisone) in the
             last 3 years

          -  Pregnancy

          -  Inability to understand or follow instructions

          -  Refusal to wear the external brace

          -  Refusal to undergo monthly chest x-rays

          -  Inability or refusal to return to UCSF for biweekly follow-up visits for the first
             month after surgery, and monthly thereafter until explant.

          -  Inability to obtain pre-approval (authorization) from the patient's insurance carrier
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael R Harrison, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Benjamin Padilla, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lan Vu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shriners Hospitals for Children</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSF-Benioff Children's Hospital</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Mercy Hospitals</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://pedsurg.ucsf.edu/research/magnetic-mini-mover-trial-study.aspx</url>
    <description>Magnetic Mini-Mover Procedure (3MP) Trial</description>
  </link>
  <reference>
    <citation>Harrison MR, Curran PF, Jamshidi R, Christensen D, Bratton BJ, Fechter R, Hirose S. Magnetic mini-mover procedure for pectus excavatum II: initial findings of a Food and Drug Administration-sponsored trial. J Pediatr Surg. 2010 Jan;45(1):185-91; discussion 191-2. doi: 10.1016/j.jpedsurg.2009.10.032.</citation>
    <PMID>20105602</PMID>
  </reference>
  <reference>
    <citation>Harrison MR, Estefan-Ventura D, Fechter R, Moran AM Jr, Christensen D. Magnetic Mini-Mover Procedure for pectus excavatum: I. Development, design, and simulations for feasibility and safety. J Pediatr Surg. 2007 Jan;42(1):81-5; discussion 85-6.</citation>
    <PMID>17208545</PMID>
  </reference>
  <reference>
    <citation>Harrison MR, Gonzales KD, Bratton BJ, Christensen D, Curran PF, Fechter R, Hirose S. Magnetic mini-mover procedure for pectus excavatum III: safety and efficacy in a Food and Drug Administration-sponsored clinical trial. J Pediatr Surg. 2012 Jan;47(1):154-9. doi: 10.1016/j.jpedsurg.2011.10.039.</citation>
    <PMID>22244409</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2011</study_first_submitted>
  <study_first_submitted_qc>March 31, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2011</study_first_posted>
  <results_first_submitted>October 24, 2017</results_first_submitted>
  <results_first_submitted_qc>May 14, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">May 17, 2018</results_first_posted>
  <last_update_submitted>May 14, 2018</last_update_submitted>
  <last_update_submitted_qc>May 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Francisco</investigator_affiliation>
    <investigator_full_name>Michael Harrison</investigator_full_name>
    <investigator_title>Professor of Surgery and Pediatrics, Emeritus</investigator_title>
  </responsible_party>
  <keyword>Pectus excavatum</keyword>
  <keyword>Chest wall deformity</keyword>
  <keyword>Magnetic Mini-Mover Procedure</keyword>
  <keyword>Pectus Severity Index</keyword>
  <keyword>pediatric medical device</keyword>
  <keyword>magnetic alteration</keyword>
  <keyword>sunken chest</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Funnel Chest</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The end results will be published in Journal of Pediatric Surgery June 2017</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Treatment Arm</title>
          <description>This is a non-randomized study in which otherwise healthy patients, ages 8-14, with severe pectus excavatum (PSI &gt; 3.5) underwent the Magnetic Mini-Mover procedure. The internal magnet, or &quot;Magnimplant&quot; was implanted on the sternum. After surgery and recovery, all subjects were fitted for an orthotic brace, the &quot;Magnatract,&quot; which is secured to the patientâ€™s chest wall by the attractive force between the coupled internal and external magnets and produces an outward force on the sternum to correct the pectus deformity.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Treatment Arm</title>
          <description>This is a non-randomized study in which otherwise healthy patients, ages 8-14, with severe pectus excavatum (PSI &gt; 3.5) will undergo the interventional treatment by having outpatient surgery, the Magnetic Mini-Mover procedure, to both place and later explant the experimental Magnimplant or Magnetic Mini-Mover device. After surgery and recovery, all subjects will be fitted for an orthotic brace, which houses the external magnet and records brace-wear compliance. They will undergo 3MP treatment for 24 months. Patients will be seen in clinic at least monthly until treatment is complete.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12" lower_limit="8" upper_limit="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
        </measure>
        <measure>
          <title>Pectus Severity Index (Haller Index)</title>
          <description>the Haller Index is calculated as a ratio by measuring across the chest internally from one rib on one side to the rib on the opposite side, then dividing the shortest distance between the spine and sternum.</description>
          <units>Ratio</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.7" lower_limit="3.6" upper_limit="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Adverse Reactions</title>
        <description>All adverse reactions were recorded and reported, including complications from implantation of the device, complications from application of the external device over time (e.g., changes in skin; infection; changes in cardiac electrical function).</description>
        <time_frame>During treatment, 24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Arm</title>
            <description>All patients who underwent the Magnetic Mini-Mover Procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Adverse Reactions</title>
          <description>All adverse reactions were recorded and reported, including complications from implantation of the device, complications from application of the external device over time (e.g., changes in skin; infection; changes in cardiac electrical function).</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Discharge home same day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal EKG after implant of magnet</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Surgical site infection</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Intact cables for implant placement</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comfort and Brace Wear During Treatment</title>
        <description>Comfort of the external brace directly affects compliance (i.e., bracewear) and compliance were be measured throughout treatment. In addition, the satisfaction of the patient and family will be measured using a standard Quality of Life (QOL) questionnaire administered 1 month after implanting the device and 1 month after removing the device.</description>
        <time_frame>During treatment, 24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment Arm</title>
            <description>All patients who underwent the Magnetic Mini-Mover Procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort and Brace Wear During Treatment</title>
          <description>Comfort of the external brace directly affects compliance (i.e., bracewear) and compliance were be measured throughout treatment. In addition, the satisfaction of the patient and family will be measured using a standard Quality of Life (QOL) questionnaire administered 1 month after implanting the device and 1 month after removing the device.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Discomfort</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Tolerated Brace wear</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Chest Wall Correction, by Pectus Severity Index</title>
        <description>Though not powered to determine efficacy, preliminary efficacy data, as measured by pre and post treatment Pectus Severity Index (Haller Index), was also collected. Pre-treatment Haller Index was assessed based on computed tomography (CT) of the chest. One month after implant removal, patients underwent repeat chest CT to evaluate chest wall correction.</description>
        <time_frame>24 months</time_frame>
        <population>All patients who have received post-treatment chest wall imaging.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Arm</title>
            <description>All patients who underwent the Magnetic Mini-Mover Procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Chest Wall Correction, by Pectus Severity Index</title>
          <description>Though not powered to determine efficacy, preliminary efficacy data, as measured by pre and post treatment Pectus Severity Index (Haller Index), was also collected. Pre-treatment Haller Index was assessed based on computed tomography (CT) of the chest. One month after implant removal, patients underwent repeat chest CT to evaluate chest wall correction.</description>
          <population>All patients who have received post-treatment chest wall imaging.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Improved</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Worsened</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Pre-treatment and post-treatment Pectus Severity Indices were compared using the Wilcoxon matched-pairs signed rank test.</non_inferiority_desc>
            <p_value>0.486</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction During the Treatment</title>
        <description>. Patients were asked to fill out questionnaire at 2 intervals: 1 month after explant and 1 year after explant</description>
        <time_frame>One month and one year after explant.</time_frame>
        <population>14 Participants offered recommendations at 2 time intervals</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment Arm</title>
            <description>All patients who underwent the Magnetic Mini-Mover Procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction During the Treatment</title>
          <description>. Patients were asked to fill out questionnaire at 2 intervals: 1 month after explant and 1 year after explant</description>
          <population>14 Participants offered recommendations at 2 time intervals</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Recommend 3MP after 1 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Recommend 3MP after 1 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with results at 1 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Satisfaction with results after 1 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 years</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Treatment Arm</title>
          <description>Magnetic Mini-Mover Procedure (Magnimplant): This is a non-randomized study in which otherwise healthy patients, ages 8-14, with severe pectus excavatum (PSI &gt; 3.5) will undergo the Magnetic Mini-Mover procedure outpatient surgery to both place and later explant the Magnimplant or Magnetic Mini-Mover device. Patients will be required to wear a custom-fitted orthotic brace, which houses the external magnet and records brace-wear compliance. They will undergo 3MP treatment for 24 months.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Nonacute cable breakage requiring explant</sub_title>
                <description>Patient with asymptomatic cable breakage discovered on screening CXR; elected to keep device. Several months later, presented with shortness of breath, symptomatic pericardial effusion, possibly due to device. Device was removed.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Acute cable breakage requiring urgent explant</sub_title>
                <description>Patient presented to clinic with a sudden anterior movement of the chest and some mild redness of the overlying skin, and a broken cable was discovered on CXR. The implant was removed the following day.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <description>One patient developed a post-operative pneumothorax following the implant procedure and was admitted overnight for chest tube placement and air evacuation.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Wound infection</sub_title>
                <description>Same patient as above (admitted for pain control) developed a superficial surgical site infection 3 weeks after the implant procedure, which resolved with an outpatient course of sulfamethoxazole / trimethoprim.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <description>One patient developed a rash on the chest wall from brace wear during warm weather, which resolved with nystatin powder.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Post-procedure hospitalization for pain control</sub_title>
                <description>Procedure planned as outpatient. However, medical team was unable to adequately control pain in post-operative care unit, and patient was admitted for 3 days for pain control following the procedure.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jill Imamura-Ching, RN</name_or_title>
      <organization>UCSF Benioff Children's Hospital</organization>
      <phone>415-476-3446</phone>
      <email>Jill.Imamura-Ching@ucsf.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

